Your browser doesn't support javascript.
loading
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
Balana, Carmen; De Las Penas, Ramon; Sepúlveda, Juan Manuel; Gil-Gil, Miguel J; Luque, Raquel; Gallego, Oscar; Carrato, Cristina; Sanz, Carolina; Reynes, Gaspar; Herrero, Ana; Ramirez, Jose Luis; Pérez-Segura, Pedro; Berrocal, Alfonso; Vieitez, Jose Maria; Garcia, Almudena; Vazquez-Estevez, Sergio; Peralta, Sergi; Fernandez, Isaura; Henriquez, Ivan; Martinez-Garcia, Maria; De la Cruz, Juan Jose; Capellades, Jaume; Giner, Pilar; Villà, Salvador.
Afiliación
  • Balana C; Medical Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Carretera Canyet, s/n, 08916, Badalona, Spain. cbalana@iconcologia.net.
  • De Las Penas R; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain.
  • Sepúlveda JM; Medical Oncology Service, Hospital Universitario, 12 de Octubre, Madrid, Spain.
  • Gil-Gil MJ; Medical Oncology Service, Institut Català d'Oncologia-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
  • Luque R; Medical Oncology Service, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Gallego O; Medical Oncology Service, Hospital de Sant Pau, Barcelona, Spain.
  • Carrato C; Pathology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Sanz C; Pathology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Reynes G; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain.
  • Herrero A; Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain.
  • Ramirez JL; Cancer Molecular Biology Laboratory, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Pérez-Segura P; Medical Oncology Service, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Berrocal A; Medical Oncology Service, Hospital General Universitario de Valencia, Valencia, Spain.
  • Vieitez JM; Medical Oncology Service, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Garcia A; Medical Oncology Service, Hospital Marqués de Valdecilla, Santander, Spain.
  • Vazquez-Estevez S; Medical Oncology Service, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Peralta S; Medical Oncology Service, Hospital Sant Joan de Reus, Reus, Spain.
  • Fernandez I; Medical Oncology Service, Hospital Xeral-Cies, Vigo, Spain.
  • Henriquez I; Radiation Oncology Service, Hospital Sant Joan de Reus, Reus, Spain.
  • Martinez-Garcia M; Medical Oncology Service, Hospital del Mar, Barcelona, Spain.
  • De la Cruz JJ; Department of Preventive Medicine and Public Health, School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Capellades J; Radiology Service, Hospital del Mar, Barcelona, Spain.
  • Giner P; Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Villà S; Radiation Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
J Neurooncol ; 127(3): 569-79, 2016 May.
Article en En | MEDLINE | ID: mdl-26847813

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2016 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2016 Tipo del documento: Article País de afiliación: España